Discontinuing Testosterone Does NOT Cause Hypertension
Based on the available evidence, stopping testosterone replacement therapy (TRT) does not cause hypertension. In fact, the opposite appears true: testosterone therapy itself may modestly increase blood pressure in some men, while lower testosterone levels are associated with higher hypertension risk through age-related mechanisms rather than withdrawal effects.
Key Evidence Analysis
What Happens During Testosterone Therapy
The FDA drug label for testosterone explicitly warns about edema and fluid retention as potential complications, particularly in patients with pre-existing cardiac, renal, or hepatic disease 1. Recent high-quality evidence demonstrates:
- Blood pressure increases during TRT: A 2024 double-blind RCT showed systolic office blood pressure increased by 6.2 mmHg in the TRT group while decreasing by 7.0 mmHg in placebo (mean difference 13.2 mmHg, P=0.01) 2
- The effect is amplified by hematocrit: The blood pressure increase during TRT was directly linked to rising hematocrit levels, with a 10 mmHg systolic increase associated with 0.3% point hematocrit rise 2
- Risk factors matter: Men with obesity or red blood cell levels in the upper normal range are more susceptible to increased blood pressure during TRT 2
What Happens After Stopping Testosterone
The evidence regarding discontinuation is limited but informative:
- A 2013 observational study found that women who stopped hormone therapy had higher rates of hypertension (27.4%) compared to those who continued (16.6%), but this was in the context of estrogen/hormone therapy in postmenopausal women, not testosterone in men 3
- No direct evidence exists showing that testosterone withdrawal causes acute hypertension in men
The Age-Testosterone-Hypertension Relationship
The relationship is correlational, not causal from withdrawal:
- Lower testosterone levels are inversely associated with hypertension incidence in men aged ≥40 years 4
- This represents a chronic age-related phenomenon, not an acute withdrawal effect
- Hypertension incidence increases with age while testosterone naturally declines 4
Clinical Implications
When Stopping TRT:
You should expect blood pressure to stabilize or potentially decrease, not increase, particularly if:
- The patient developed polycythemia during treatment (hematocrit >52%) 5
- There was fluid retention during therapy
- Blood pressure increased during TRT
Monitor for the "Roller Coaster Effect":
With injectable testosterone, patients experience fluctuating symptoms corresponding to testosterone level variations 5. After discontinuation:
- Symptoms return to baseline hypogonadal state over 10-14 days for short-acting preparations
- This is not a withdrawal syndrome causing new pathology like hypertension
Important Caveats:
- Polycythemia resolution: The elevated hematocrit from TRT (occurring in 3-44% depending on formulation) 5 will normalize after discontinuation, which should improve rather than worsen cardiovascular risk
- Cardiovascular safety: The TRAVERSE trial (2023) demonstrated cardiovascular noninferiority of TRT versus placebo in high-risk men 6, but noted higher incidence of atrial fibrillation, acute kidney injury, and pulmonary embolism with testosterone
- Long-term effects: One registry study showed TRT was associated with lowering of blood pressure during follow-up, with greater reductions in men with higher baseline BP 7
Bottom Line
Discontinuing testosterone does not cause hypertension. If anything, stopping TRT may lead to modest blood pressure reduction, especially in men who developed polycythemia or fluid retention during treatment. The association between low testosterone and hypertension reflects chronic age-related changes, not acute withdrawal effects. Monitor blood pressure after discontinuation as part of routine care, but do not expect or attribute new-onset hypertension to testosterone cessation.